At close: January 7 at 4:00:01 PM EST
After hours: 7:46:36 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-108,878.00
-85,688.00
-75,143.00
-59,541.00
-45,268.00
Investing Cash Flow
445.00
-43,403.00
-109,248.00
158,435.00
-215,959.00
Financing Cash Flow
126,425.00
85,658.00
25,225.00
49,134.00
250,514.00
End Cash Position
44,721.00
23,875.00
67,308.00
226,474.00
78,446.00
Capital Expenditure
-1,026.00
-849.00
-2,078.00
-939.00
-667.00
Issuance of Capital Stock
125,000.00
85,000.00
25,000.00
50,000.00
271,308.00
Free Cash Flow
-109,904.00
-86,537.00
-77,221.00
-60,480.00
-45,935.00
12/31/2020 - 4/24/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
KYMR Kymera Therapeutics, Inc.
40.92
+2.56%
ITOS iTeos Therapeutics, Inc.
7.83
-2.85%
OLMA Olema Pharmaceuticals, Inc.
5.24
-4.73%
ZNTL Zentalis Pharmaceuticals, Inc.
2.9900
-4.47%
STOK Stoke Therapeutics, Inc.
9.31
-15.52%
PLRX Pliant Therapeutics, Inc.
13.27
+0.68%
ALXO ALX Oncology Holdings Inc.
1.8600
+3.91%
CGEM Cullinan Therapeutics, Inc.
11.56
-1.87%
INZY Inozyme Pharma, Inc.
2.8200
-2.42%
DSGN Design Therapeutics, Inc.
5.92
-6.18%